Beacon Pointe Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,900
Closed -$99K 1006
2022
Q2
$99K Buy
11,900
+967
+9% +$13.5K ﹤0.01% 1008
2022
Q1
$250K Buy
10,933
+804
+8% +$19.7K ﹤0.01% 1043
2021
Q4
$280K Hold
10,129
0.01% 760
2021
Q3
$282K Sell
10,129
-4,451
-31% -$126K 0.01% 725
2021
Q2
$427K Buy
14,580
+3,075
+27% +$93.2K 0.02% 534
2021
Q1
$366K Sell
11,505
-6,300
-35% -$185K 0.02% 345
2020
Q4
$368K Sell
17,805
-2,430
-12% -$45.3K 0.03% 328
2020
Q3
$314K Hold
20,235
0.03% 291
2020
Q2
$370K Buy
+20,235
New +$357K 0.04% 274

Other funds holding BHC

Beacon Pointe Advisors's BHC Position: Q3 2022 in Review

Beacon Pointe Advisors sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 11,900 shares — an estimated $99K sold.

Beacon Pointe Advisors first reported a position in BHC in Q2 2020 and held it in 9 quarters. The position peaked at $427K in Q2 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Beacon Pointe Advisors reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Beacon Pointe Advisors sold 11,900 Bausch Health shares in Q3 2022, an estimated $99K.
  • Beacon Pointe Advisors first reported a position in Bausch Health in Q2 2020 and held it in 9 quarters.
  • Beacon Pointe Advisors's Bausch Health position peaked at $427K in Q2 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Beacon Pointe Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.